INTERNATIONAL SYMPOSIUM ON ENDOVASCULAR THERAPEUTICS (SITE). SEPTEMBER 20 & 21, 2021. BARCELONA, SPAIN

 

https://www.sitesymposium.com/site-2021/

CORONAVIRUS STATUS. AUGUST 4, 2021

 

CORONAVIRUS STATUS. JULY 2, 2021

 

SVS VASCULAR MEETING. SAN DIEGO, CALIFORNIA. AUGUST 18 - 21, 2021

 https://vascular.org/vam

CORONAVIRUS STATUS. JUNE 8, 2021

 

SURGICAL TREATMENT / AHA/ASA GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE

 

SYMPTOMATIC CAROTID ARTERY DISEASE ESVS GUIDELINES

 

CORONAVIRUS STATUS. MAY 1, 2021

 

The Impact of the COVID-19 Pandemic on Vascular Surgery Trainees in the United States

The Impact of the COVID-19 Pandemic on Vascular Surgery Trainees in the United States

Ann Vasc Surg 2021; 72: 182–190 https://doi.org/10.1016/j.avsg.2020.09.045
2020 Elsevier Inc. All rights reserved. Manuscript received: August 20, 2020; manuscript accepted: September 16, 2020; published online: 3 November 2020

NATURAL HISTORY OF PERIPHERAL ARTERY DISEASE

ATLAS OF VASCULAR DISEASE

Mark Creager

 

TREATMENTS TARGETS AND GOALS FOR CARDIOVASCULAR DISEASE PREVENTION

 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

THE IWGDF 2019 RISK STRATIFICATION SYSTEM

 IWGDF GUIDELINES 2019

CORONAVIRUS STATUS, APRIL 1, 2021

 

JORNADAS DE ACTUALIZACIÓN EN INSUFICIENCIA VENOSA CRÓNICA

Miércoles 10 de marzo de 2021 a las 20h00

Miércoles 17 de marzo de 2021 a las 20h00

Miércoles 24 de marzo de 2021 a las 20h00

 

CORONAVIRUS STATUS. MARCH 3, 2021